{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:9928"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:9928","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Development and evaluation of human ex vivo normothermic machine liver perfusion for viability testing and investigation of the role of TWEAK/Fn14 in ischaemia reperfusion injury","abstract":"Liver disease is characterised by ongoing inflammation and regeneration the mechanism of which is incompletely understood, although the Fn14/TWEAK receptor-ligand system may play a role in cholangiopathies. Currently, the only treatment for end stage disease is transplantation. This thesis describes the development of ex vivo Normothermic Machine Liver Perfusion of discarded human livers for viability testing, before validation by transplantation and assessment as a novel model of ischaemia-reperfusion injury. Biliary epithelial cells were isolated, Fn14 expression determined and functional activity of Fn14 stimulation by TWEAK established using existing in vitro modelling. Ex vivo Normothermic Machine Liver Perfusion was evaluated as a model of Fn14 expression. Perfusate lactate <2.0mmol/L after 2 hours of normothermic perfusion and delta lactate concentrations were key determinants in the viability of discarded human livers. Viability could be predicted earlier using proteomics at commencement of perfusion. Evolution of this model included using a bovine haemoglobin-based oxygen carrier as the perfusate and successful liver splitting with concurrent perfusion. This ex vivo human system then investigated the potential role of Fn14 in this newly established, validated model. Normothermic Machine Liver Perfusion has a significant role in determining viability of discarded human livers and establishing the Machine Criteria Donor","abstract_html":"Liver disease is characterised by ongoing inflammation and regeneration the mechanism of which is incompletely understood, although the Fn14/TWEAK receptor-ligand system may play a role in cholangiopathies. Currently, the only treatment for end stage disease is transplantation. This thesis describes the development of ex vivo Normothermic Machine Liver Perfusion of discarded human livers for viability testing, before validation by transplantation and assessment as a novel model of ischaemia-reperfusion injury. Biliary epithelial cells were isolated, Fn14 expression determined and functional activity of Fn14 stimulation by TWEAK established using existing in vitro modelling. Ex vivo Normothermic Machine Liver Perfusion was evaluated as a model of Fn14 expression. Perfusate lactate &lt;2.0mmol/L after 2 hours of normothermic perfusion and delta lactate concentrations were key determinants in the viability of discarded human livers. Viability could be predicted earlier using proteomics at commencement of perfusion. Evolution of this model included using a bovine haemoglobin-based oxygen carrier as the perfusate and successful liver splitting with concurrent perfusion. This ex vivo human system then investigated the potential role of Fn14 in this newly established, validated model. Normothermic Machine Liver Perfusion has a significant role in determining viability of discarded human livers and establishing the Machine Criteria Donor","abstract_has_math":false,"creators":["Stephenson, Barney"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2020,"date_issued":"2020-07","date_published":"2020-07","updated_at":"2026-11-19T09:30:56Z","subjects":["QR180 Immunology","RC Internal medicine"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/9928/1/Stephenson2020PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A9928","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["mrc"]},{"key":"dc:creator","label":"Author","values":["Stephenson, Barney"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2020-07"]},{"key":"dc:date.issued","label":"Date","values":["2020-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Immunology and Immunotherapy"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/9928/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QR180 Immunology","RC Internal medicine"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/9928/1/Stephenson2020PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Liver disease is characterised by ongoing inflammation and regeneration the mechanism of which is incompletely understood, although the Fn14/TWEAK receptor-ligand system may play a role in cholangiopathies. Currently, the only treatment for end stage disease is transplantation. This thesis describes the development of ex vivo Normothermic Machine Liver Perfusion of discarded human livers for viability testing, before validation by transplantation and assessment as a novel model of ischaemia-reperfusion injury. Biliary epithelial cells were isolated, Fn14 expression determined and functional activity of Fn14 stimulation by TWEAK established using existing in vitro modelling. Ex vivo Normothermic Machine Liver Perfusion was evaluated as a model of Fn14 expression. Perfusate lactate <2.0mmol/L after 2 hours of normothermic perfusion and delta lactate concentrations were key determinants in the viability of discarded human livers. Viability could be predicted earlier using proteomics at commencement of perfusion. Evolution of this model included using a bovine haemoglobin-based oxygen carrier as the perfusate and successful liver splitting with concurrent perfusion. This ex vivo human system then investigated the potential role of Fn14 in this newly established, validated model. Normothermic Machine Liver Perfusion has a significant role in determining viability of discarded human livers and establishing the Machine Criteria Donor"]},{"key":"dc:format","label":"Dc Format","values":["text"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Development and evaluation of human ex vivo normothermic machine liver perfusion for viability testing and investigation of the role of TWEAK/Fn14 in ischaemia reperfusion injury"]}]}],"canonical_facts":{"dc:contributor.sponsor":["mrc"],"dc:creator":["Stephenson, Barney"],"dc:date":["2020-07"],"dc:date.issued":["2020-07"],"dc:description.abstract":["Liver disease is characterised by ongoing inflammation and regeneration the mechanism of which is incompletely understood, although the Fn14/TWEAK receptor-ligand system may play a role in cholangiopathies. Currently, the only treatment for end stage disease is transplantation. This thesis describes the development of ex vivo Normothermic Machine Liver Perfusion of discarded human livers for viability testing, before validation by transplantation and assessment as a novel model of ischaemia-reperfusion injury. Biliary epithelial cells were isolated, Fn14 expression determined and functional activity of Fn14 stimulation by TWEAK established using existing in vitro modelling. Ex vivo Normothermic Machine Liver Perfusion was evaluated as a model of Fn14 expression. Perfusate lactate <2.0mmol/L after 2 hours of normothermic perfusion and delta lactate concentrations were key determinants in the viability of discarded human livers. Viability could be predicted earlier using proteomics at commencement of perfusion. Evolution of this model included using a bovine haemoglobin-based oxygen carrier as the perfusate and successful liver splitting with concurrent perfusion. This ex vivo human system then investigated the potential role of Fn14 in this newly established, validated model. Normothermic Machine Liver Perfusion has a significant role in determining viability of discarded human livers and establishing the Machine Criteria Donor"],"dc:format":["text"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/9928/1/Stephenson2020PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Immunology and Immunotherapy"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/9928/"],"dc:subject":["QR180 Immunology","RC Internal medicine"],"dcterms:accessrights":["public"],"dc:title":["Development and evaluation of human ex vivo normothermic machine liver perfusion for viability testing and investigation of the role of TWEAK/Fn14 in ischaemia reperfusion injury"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"]},"updated_at":"2026-11-19T09:30:56Z"}